Holen Sie sich die Stockscreener-App
1.00
6.54%
-0.07
Schlusskurs vom Vortag:
$1.07
Offen:
$1.08
24-Stunden-Volumen:
130.46K
Relative Volume:
0.66
Marktkapitalisierung:
$47.90M
Einnahmen:
$2.72M
Nettoeinkommen (Verlust:
$-85.08M
KGV:
-0.5181
EPS:
-1.93
Netto-Cashflow:
$-70.93M
1W Leistung:
+1.03%
1M Leistung:
+11.97%
6M Leistung:
-0.50%
1J Leistung:
-86.89%
1-Tages-Spanne:
$1.00
$1.1199
1-Wochen-Bereich:
$0.99
$1.13
52-Wochen-Spanne:
$0.6922
$7.681
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Vergleichen Sie STTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
1.00 | 47.41M | 2.72M | -85.08M | -70.93M | -1.93 |
|
ONC
Beigene Ltd Adr
|
238.76 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.03 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.85 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.69 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Dimensional Fund Advisors LP Sells 109,300 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Average PT from Brokerages - Defense World
LAWSUITS FILED AGAINST STTK, ASTR and CELHJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Lawsuits Filed Against STTK, EDU and ASTR – Jakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST BMBL, STTK and SPWRJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST STTK, RIVN and AIJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Renaissance Technologies LLC Reduces Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Renaissance Technologies LLC Sells 222,500 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - The AM Reporter
Shattuck Labs Advances SL-325 Program Amid Financial Progress - TipRanks
LAWSUITS FILED AGAINST FSLR, CLVT and STTKJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Bought by JPMorgan Chase & Co. - Defense World
Shattuck Labs First Quarter 2025 Earnings: US$0.27 loss per share (vs US$0.37 loss in 1Q 2024) - Yahoo Finance
STTK Prepares for Phase 1 Clinical Trial of SL-325 | STTK Stock News - GuruFocus
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - The Manila Times
Shattuck Labs Inc (STTK) Reports Q1 2025 EPS of -$0.27, Narrowly Beating Estimates - GuruFocus
Shattuck Labs Reports First Quarter 2025 Financial Results and R - GuruFocus
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs, Inc. SEC 10-Q Report - TradingView
Shattuck Labs Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
STTK STOCK ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Lawsuits Filed Against CHGG, STTK and EDUJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Google Earnings: The One Metric That No One Saw Coming - The Globe and Mail
Shattuck Labs (STTK) to Release Earnings on Thursday - Defense World
HVAC and Water Systems Stocks Q4 In Review: Advanced Drainage (NYSE:WMS) Vs Peers - The Globe and Mail
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Average Price Target from Analysts - Defense World
Shattuck Labs at 24th Annual Needham Conference: Strategic IBD Focus By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
3 Promising Penny Stocks With Market Caps Under $300M - simplywall.st
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Acute Myeloid Leukemia Treatment Market 2034: Clinical Trials, - openPR.com
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
24,446 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Virtu Financial LLC - Defense World
Biotech Spotlight: Shattuck Labs CEO Set for Major Investor Presentation at Needham Conference - Stock Titan
STTK stock plunges to 52-week low, touches $0.93 - Investing.com
Brokers Issue Forecasts for Shattuck Labs Q1 Earnings - Defense World
515,619 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Takeda Pharmaceutical Co. Ltd. - MarketBeat
H.C. Wainwright holds Shattuck Labs stock at Neutral - Investing.com
Shattuck Labs Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Shattuck Labs (NASDAQ:STTK) Given Neutral Rating at HC Wainwright - Defense World
Shattuck Labs’ (STTK) “Hold” Rating Reaffirmed at Needham & Company LLC - Defense World
Shattuck Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Shattuck Labs Inc (STTK) Q4 2024 Earnings: EPS of -$0.37 Misses Estimate, Revenue of $0.71M Below Expectations - GuruFocus
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
6.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):